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For a viral illness first described a thousand years ago, vaccine-preventable for 50 years, and 
eliminated from the USA in 2000, the interest associated with measles in 2015 is notable [1–
4]. Most virologists only dream of a solution as successful as live-attenuated measles 
vaccine, with 97% two-dose efficacy and literally billions ‘served.’ Success can breed 
complacency, skepticism or even attack. All these reactions play a role in the current US 
experience with measles. The dynamics involved with recent US measles outbreaks may 
have more to do with cultural attitudes and consumer behavior than with R0 and airborne 
transmission.
From 4 January to 10 April 2015, 159 people were reported to have measles in the USA [1]. 
Seventy percent of cases are part of an outbreak associated with Disney amusement parks in 
Southern California. Eighteen states and the District of Columbia have identified measles 
cases so far this year, with multiple genotypes (B3, D4, D8, D9 and H1) detected. Based on 
available information, 45% of the reported cases occurred in people who were never 
vaccinated (68 of 155 US residents), while more than a third (60 or 38%) had unknown 
vaccination status. Of those who had not been vaccinated, 29 (43%) were unvaccinated 
because of personal, philosophical or parental beliefs, while 26 (35%) were too young to 
receive the vaccine. Cases with links back to the Disney parks occurred in seven states, 
Mexico and Canada. In 2015, smaller outbreaks unrelated to the amusement parks have 
involved a childcare center in Illinois, extended family in Washington State, and community 
exposures in Nevada.
In order to declare that measles was eliminated in the USA in 2000, authorities determined 
that indigenous circulation of the virus for more than 12 months had been interrupted [5]. 
Cases detected since 2000 have been directly or indirectly linked to importation of the virus 
from endemic areas, and transmission from such importations has not resulted in sustained 
chains of transmission. In the first decade of the elimination era in the USA, a median of 60 
measles cases were reported annually (range: 37–220) and an average of 33 annual 
importations occurred. Outbreaks were relatively small (3–34 cases), but each still required 
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extensive public health responses. Since 2011, about twice as many importations occurred 
most years (range: 21–80), with a median of 205 annual cases. Some larger outbreaks (58–
383 cases) occurred, affecting a variety of religious congregations characterized by very low 
immunization rates [6,7]. Although the period from 2000 through 2014 was associated with 
substantial reductions in measles-related deaths around the world, particularly in Africa [8], 
Americans traveling abroad still could easily encounter the virus, especially during travel in 
Europe and Asia. When the virus is imported to the USA, clustering of underimmunized 
individuals provides fertile ground for extensive spread and represents a threat to sustaining 
elimination within the USA [9].
Importations to the USA can be evaluated based on travel history, molecular epidemiology 
(i.e., genotyping) or both. The frequency of importations from particular regions reflects the 
volume of travelers and state of measles immunization in particular destinations. The 
majority of measles importations occur after Americans travel abroad, rather than from 
international visitors to the USA. Importations from Latin America have virtually ceased 
since countries within the Pan American Health Organization Region first interrupted 
transmission in 2004. Recently, large measles outbreaks in France (2010–2011) and the 
Philippines (2013–2014) accounted for numerous importations. The California Disney-
associated outbreak is caused by genotype B3, which has been circulating in 14 different 
countries within the past 6 months, and the source of the outbreak has not been determined.
Vaccinating one's children continues to be a social norm in the USA. Less than 1% of 19–
35-month olds have received no vaccines, and 92% of toddlers have received at least one 
dose of MMR [10]. Two-dose coverage with MMR among the nation's kindergarten students 
is also high (median: 94.7%, range: 81.7% in Colorado to 99.7% in Mississippi) [11]. 
However, high MMR coverage at the national and state level can mask much lower coverage 
in specific communities, schools or within social networks [12]. Recent analysis of 
immunization patterns in California revealed geographic clusters where underimmunization 
with MMR and vaccine refusal were more common [9]). Analysis of measles cases in the 
past several years suggests a pattern – many of those who were not vaccinated had exempted 
due to personal beliefs, some had delayed receipt of the vaccine and an important portion 
were <12 months of age, i.e., too young to be vaccinated routinely [1,13–14]. Refusal or 
delay in vaccination may result from a variety of concerns, including parents' desire to 
reduce the number of shots a child receives on a particular visit, reluctance to accept 
vaccinations if mild illness is present, concern about risk of adverse events and belief that 
vaccine-preventable disease is not a risk to one's child. Although surveys of parents reveal 
relatively stable confidence in vaccines and vaccine safety, a persistent, sizable portion of the 
general population still believes that vaccines may cause autism, even though there have 
been numerous studies finding no such association, the original article proposing this link 
has been retracted and exhaustive reviews by the Institute of Medicine and others have found 
no association [15].
Infants are at particular risk of measles and its complications. MMR vaccination in the USA 
targets children at 12–15 months and 4–6 years of age for routine immunization. The 
presence of maternal antibody to measles in the first several months of life blunts the 
response to vaccination. Vaccination between 6 and 11 months can provide short-term 
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protection, and is recommended for infants who are traveling internationally where measles 
is endemic, but two additional doses beginning at 12 months of age are still needed to assure 
long-term protection. Protection of infants and others who cannot themselves be vaccinated 
(e.g., persons with immunosuppressive conditions for whom live viral vaccines are 
contraindicated) depends on very high population immunity to measles. The introduction of 
measles virus into communities where unimmunized people cluster, as through a returning 
traveler, can lead to outbreaks among those susceptible. One outbreak in 2015 occurred at a 
child care center in Illinois, where nearly all of the unimmunized infants less than 1 year of 
age in the classroom developed measles. Thus far, high immunization rates in the USA have 
provided the herd immunity that has sustained elimination of measles.
One factor contributing to pockets of underimmunization is the clustering of children who 
have exempted from school requirements for MMR vaccine. An outbreak of measles in San 
Diego in 2008 revealed that some schools had more than 20% of children exempting from 
MMR vaccination [12]. Several studies have found that the higher the proportion of school 
children with exemptions, the higher the risk of disease and/or outbreaks due to measles or 
pertussis [16–18]. Other studies have linked policies where exemptions are easily obtained 
with higher proportions of children with exemptions, and some data suggest that increasing 
the rigor required for exemptions can lead to a reduction in people obtaining exemptions 
[19]. States vary in the approach for administrative implementation of exemption policies. 
State requirements are being reexamined by several legislatures in the wake of the 2015 
Disney outbreak [20].
What then can be done to be sure that measles does not reestablish a foothold in the USA? 
Continued commitment from clinicians seeing young children is vital, as healthcare 
professionals hold the greatest influence on parents' vaccination decisions. Reinforcement of 
system checks (e.g., verifying vaccine history for child care, kindergarten and middle school 
entry) is also critical. Better use of Immunization Information Systems (IIS), especially to 
make sure that adults have documentation of vaccines received across the lifespan, can 
improve understanding of the evolving epidemiology of measles in the postelimination era. 
A national survey of serologic evidence of immunity demonstrated that more than 90% of 
adults have immunity against measles [21]. Continued efforts at global control of vaccine 
preventable diseases, including achieving regional targets for measles elimination, will 
reduce importation risk and ultimately achieve a world without unnecessary deaths from 
measles.
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